Success Story: From Obesity-Related Disease Research to NIW Approval for a Biomedical Researcher from Chile
Client’s Testimonial:
“Thank you so much for all your help and support!”
On August 26th, 2026, we received another O1-A (Individuals with Extraordinary Ability or Achievement) approval for a Founding Member of Technical Staff in the Field of Computational Chemistry and Materials Discovery (Approval Notice).
On August 11th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Visiting Fellow in the Field of Biomedical Research (Approval Notice).
General Field: Biomedical Research
Position at the Time of Case Filing: Postdoctoral Visiting Fellow
Country of Origin: Chile
State of Residence at the Time of Filing: Maryland
Approval Notice Date: August 11th, 2026
Processing Time: 6 months, 28 days (Premium Processing Requested)
Case Summary:
As obesity and related metabolic diseases continue to place major pressure on public health systems, researchers face an important challenge: identifying the molecular mechanisms that drive these conditions and finding better ways to support prevention and treatment. Our client, an expert in biomedical research with a Ph.D. in medical sciences, has built a research record addressing these broader healthcare needs. We represented the client in an I-140 National Interest Waiver (NIW) petition, which was ultimately approved after a Request for Evidence (RFE).
The client’s proposed endeavor focuses broadly on studying biological mechanisms related to obesity and associated health conditions using modern research approaches. The petition emphasized the client’s work in improving scientific understanding of metabolic processes, disease development, and related biological pathways that may contribute to future medical advances and treatment strategies.
The client currently works as a postdoctoral visiting fellow at a U.S. federal biomedical research institute, where the client conducts biomedical research. The petition connected this ongoing work to broader U.S. interests in public health, biotechnology, chronic disease prevention, metabolic disease research, and healthcare cost reduction.
To demonstrate that the client was well positioned to continue this endeavor, we presented several complementary indicators of research productivity and influence:
- 7 peer-reviewed journal articles, including 1 first-authored article and 1 co-first-authored article
- 16 first-authored abstracts
- 1 first-authored preprint
- 177 citations to the client’s published research
- At least 8 completed peer reviews
The petition did not rely on these figures as accomplishments that spoke for themselves. Instead, we showed how independent researchers had incorporated the client’s findings into subsequent studies involving broader areas of metabolism, cellular function, and disease mechanisms related to obesity and metabolic health.
Several publications also ranked among highly cited Molecular Biology and Genetics papers for their respective publication years, including 2 within the top 10% and 1 within the top 20%. This comparative evidence helped demonstrate that the client’s work had attracted attention beyond ordinary citation patterns for similarly aged research.
We further documented research support from major federal funding sources, including the National Institutes of Health, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Cancer Institute. This funding provided another objective indicator of interest in research areas connected to the client’s broader work. Taken together, the client’s scholarly output, citation record, independently documented use of the research, funding support, technical background, peer-review service, and continuing research plans demonstrated a sustained trajectory rather than isolated achievements.
The approval of the client’s I-140 NIW petition represents an important milestone in this continuing research journey. We are pleased to have helped present a case grounded not simply in numerical credentials, but in evidence showing how the client’s work has gained independent recognition and can continue contributing to biomedical research, obesity-related disease studies, multi-omics analysis, and metabolic health research in the United States.